<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01877577</url>
  </required_header>
  <id_info>
    <org_study_id>IBDVitD-42012</org_study_id>
    <nct_id>NCT01877577</nct_id>
  </id_info>
  <brief_title>Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D</brief_title>
  <official_title>Supplementation of Vitamin D3 (Cholecalciferol) in Patients With Inflammatory Bowel Diseases (IBD) and Hypovitaminosis D: A Prospective Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the effect of vitamin D3 supplementation on disease activity and
      quality of life in IBD patients deficient in vitamin D, and also help determine the optimal
      dose of vitamin D3 for them.

      Hypothesis: Supplementation of vitamin D3 in IBD patients with hypovitaminosis D can improve
      their quality of life and decrease IBD activity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of hypovitaminosis D has been reported to be as high as 75% in patients with
      IBD. However, it is unclear whether low vitamin D levels contribute to the pathogenesis of
      IBD or are a consequence of IBD. Recent animal data studies suggest that maintenance of the
      epithelial barrier integrity in the large intestine by vitamin D is important in preventing
      IBD.

      However, more evidence is required to determine the effect of vitamin D3 supplementation in
      patients with IBD. Furthermore, there is no clear consensus regarding the appropriate dose of
      vitamin D supplementation in IBD patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vitamin D3 supplementation in IBD patients with hypovitaminosis D.</measure>
    <time_frame>90 days after patient taking the Vitamin D3 supplement daily</time_frame>
    <description>To determine the appropriate dose of vitamin D3 supplementation in IBD patients with hypovitaminosis D.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vitamin D3 supplementation on disease activity and quality of life</measure>
    <time_frame>90 days after patient taking the Vitamin D3 supplement daily</time_frame>
    <description>To assess the effect of vitamin D3 supplementation on IBD disease activity and quality of life in patients with IBD and hypovitaminosis D.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Crohn's Disease (CD)</condition>
  <condition>Ulcerative Colitis (UC)</condition>
  <arm_group>
    <arm_group_label>2000 I/U Vitamin D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2000 I/U Vitamin D3 Daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4000 I/U Vitamin D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4000 I/U Vitamin D3 Daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>Study patients who took 2,000 IU daily of vitamin D3 will be compared to those who took 4,000 IU daily to determine the different effects of vitamin D3 dose on quality of life, disease activity, and the laboratory tests in this study.</description>
    <arm_group_label>2000 I/U Vitamin D3</arm_group_label>
    <arm_group_label>4000 I/U Vitamin D3</arm_group_label>
    <other_name>vitamin D3 cholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis)

          -  18 years of age or older

          -  25(OH)D levels &lt;30ng/ml

          -  willing to give informed written consent

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Women who are pregnant or planning to become pregnant

          -  Patients already taking vitamin D3 â‰¥2,000 IU/daily prior to study enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Limsui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Clinical Professor, UCSF</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Community Regional Medical Center, Ambulatory Care Center</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93721</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011 Jun 15;474(7351):307-17. doi: 10.1038/nature10209. Review.</citation>
    <PMID>21677747</PMID>
  </reference>
  <reference>
    <citation>Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011 May;35(3):308-16. doi: 10.1177/0148607110381267.</citation>
    <PMID>21527593</PMID>
  </reference>
  <reference>
    <citation>Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, Li YC. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G208-16. Epub 2007 Oct 25.</citation>
    <PMID>17962355</PMID>
  </reference>
  <reference>
    <citation>Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011 Jan;96(1):53-8. doi: 10.1210/jc.2010-2704. Epub 2010 Nov 29.</citation>
    <PMID>21118827</PMID>
  </reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2013</study_first_submitted>
  <study_first_submitted_qc>June 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2013</study_first_posted>
  <last_update_submitted>July 1, 2014</last_update_submitted>
  <last_update_submitted_qc>July 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Avitaminosis</mesh_term>
    <mesh_term>Rickets</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

